文献速递血栓与止血

巨噬细胞清除在肥胖的ADAMTS-13缺陷小鼠中挽救血小板并降低血栓性血小板减少性紫癜风险

Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
PubMed 文献 · J Thromb Haemost · 2017-11-28

该研究在肥胖与瘦的Adamts-13-/-及野生型小鼠中注射重组人血管性血友病因子(rVWF)250 U kg-1,24小时后评估血栓性血小板减少性紫癜(TTP)特征。肥胖Adamts-13-/-小鼠出现重度血小板减少和更高乳酸脱氢酶(LDH)水平,而瘦小鼠未发生TTP;用氯膦酸盐脂质体清除肝脾巨噬细胞可保留肥胖Adamts-13-/-小鼠24小时后的血小板计数,体外实验证实VWF剂量依赖性增强巨噬细胞对血小板的吞噬。

要点

  • 肥胖Adamts-13-/-小鼠血小板计数低于瘦 counterparts,更易发生TTP相关血小板减少。
  • 清除肝脾巨噬细胞可保留肥胖Adamts-13-/-小鼠注射rVWF后24小时的血小板计数。
  • 体外培养巨噬细胞证实VWF剂量依赖性增加血小板吞噬。

核心结论

  • 肥胖Adamts-13-/-小鼠比瘦小鼠更易发生TTP相关血小板减少,巨噬细胞对血小板的吞噬在该模型rVWF注射后血小板减少中起作用。

研究设计与样本

  • 研究比较瘦与肥胖的Adamts-13-/-和野生型(WT)小鼠,注射250 U kg-1重组人VWF(rVWF)后24小时评估TTP特征。
  • 另在注射rVWF前48小时经氯膦酸盐脂质体清除瘦与肥胖WT或Adamts-13-/-小鼠肝脾巨噬细胞。
  • 体外实验使用培养的巨噬细胞评估VWF对血小板吞噬的影响。

主要发现

  • 肥胖Adamts-13-/-小鼠血小板计数低于瘦 counterparts。
  • 瘦Adamts-13-/-小鼠以阈值剂量rVWF触发未发生TTP,而肥胖Adamts-13-/-小鼠出现典型TTP症状包括重度血小板减少和更高LDH水平。
  • 肥胖Adamts-13-/-小鼠注射rVWF前清除肝脾巨噬细胞,可保留24小时后的血小板计数。
  • 体外培养巨噬细胞证实VWF剂量依赖性增加血小板吞噬。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP). Obese ADAMTS-13-deficient mice were triggered with von Willebrand factor (VWF). Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model. VWF enhances phagocytosis of platelets by macrophages, dose-dependently. SUMMARY: Background Thrombotic thrombocytopenic purpura (TTP) is caused by the absence of ADAMTS-13 activity. Thrombocytopenia is presumably related to the formation of microthrombi rich in von Willebrand factor (VWF) and platelets. Obesity may be a risk factor for TTP; it is associated with abundance of macrophages that may phagocytose platelets. Objectives To evaluate the role of obesity and ADAMTS-13 deficiency in TTP, and to establish whether macrophages contribute to thrombocytopenia. Methods Lean or obese ADAMTS-13-deficient (Adamts-13-/- ) and wild-type (WT) mice were injected with 250 U kg-1 of recombinant human VWF (rVWF), and TTP characteristics were evaluated 24 h later. In separate experiments, macrophages were depleted in the liver and spleen of lean and obese WT or Adamts-13-/- mice by injection of clodronate-liposomes, 48 h before injection of rVWF. Results Obese Adamts-13-/- mice had a lower platelet count than their lean counterparts, suggesting that they might be more susceptible to TTP development. Lean Adamts-13-/- mice triggered with a threshold dose of rVWF did not develop TTP, whereas typical TTP symptoms developed in obese Adamts-13-/- mice, including severe thrombocytopenia and higher lactate dehydrogenase (LDH) levels. Removal of hepatic and splenic macrophages by clodronate injection in obese Adamts-13-/- mice before treatment with rVWF preserved the platelet counts measured 24 h after the trigger. In vitro experiments with cultured macrophages confirmed a VWF dose-dependent increase of platelet phagocytosis. Conclusions Obese Adamts-13-/- mice are more susceptible to the induction of TTP-related thrombocytopenia than lean mice. Phagocytosis of platelets by macrophages contributes to thrombocytopenia after rVWF injection in this model.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Geys L, Roose E, Scroyen I, et al. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2017. PMID: 29121438. doi:10.1111/jth.13901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。